Medical devices, healthcare technology and the business of care
510(k) clearance · K260671

RP Check (RP01)

MD Diagnostics, Ltd. · Decision date Oct 26, 2026

MEDTECHLEDGER EXPLANATIONK260671

What did the FDA decide?

FDA recorded a substantially equivalent decision for K260671, RP Check (RP01), submitted by MD Diagnostics, Ltd., with a decision date of 2026-10-26. The listing places the submission under the Anesthesiology specialty with product code CAP. Substantially equivalent in the 510(k) pathway denotes clearance to market, not premarket approval of a new device.

The available record identifies the device by trade name and model designation only. It does not describe the device's components, intended use, technological characteristics, or any predicate device, and no summary of the cleared indications is present in the source. The relationship to any earlier submission by this applicant is likewise unstated. Researchers should treat the clearance scope as unknown pending the underlying FDA decision documents.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Anesthesiology
Decision date
Oct 26, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260671
Regulatory pathway
510(k) premarket notification
Product code
CAP
Decision code
SESE
Decision date
Oct 26, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Monitor, Airway Pressure (Includes Gauge And/Or Alarm).

Product code
CAP
FDA device class
2

FDA decision timeline

  1. K260671 received

    Application receipt date recorded by FDA.

  2. K260671 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

MD Diagnostics, Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Chatham

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records